<!DOCTYPE html>
<html>

<head>
    <style type="text/css">
        p {
            opacity: 0;
        }

        /* title */
        .title-box-new {
            /* margin: 5vw 5vw 2vw 5vw; */
            position: relative;
            width: 100%;

        }

        .title-big h1 {
            font-size: 6vw !important;
            /* line-height:14vw; */

        }

        .title-big>.title-box-title {
            border-left-style: none !important;
            border-bottom-style: solid;
            border-color: rgb(255, 55, 68);
            border-bottom-width: 0.2vw;

        }

        .title-box-mask {
            position: absolute;

            height: 100%;

            background-color: rgb(255, 55, 68);
        }

        .title-box-mask-left {
            left: 0;
        }

        .title-box-mask-right {
            right: 0;
        }

        .title-box-title {
            /* width: 100%; */
            height: inherit;
            border-left-style: solid;
            border-color: rgb(255, 55, 68);
            border-left-width: 0.25rem;
            opacity: 0;
            display: flex;
            /* justify-content-design: center; */


        }

        .title-big h1 {
            flex-grow: 1;
            vertical-align: middle;
            text-align: center;
            margin: 0;
            font-size: 8rem;
            color: rgb(25, 46, 67);
        }

        .title-box-title>h1 {
            /* flex-grow: 1; */
            vertical-align: middle;
            /* text-align:center; */
            padding: 0 4rem;
            margin: 0;
            font-size: 8rem;
            color: rgb(25, 46, 67);
        }

        /* title end */
        /* reference */

        /* reference end */
        /* content-design start */
        /* arrow start */
        .arrow {
            opacity: 0;
        }

        .arrow_1 {
            display: flex;
            align-items: center;
            justify-content: center;
        }

        .arrow_1>img {
            width: 15vw;
        }

        .arrow_2 {
            display: flex;
            align-items: center;
            justify-content: center;
        }

        .arrow_2>img {
            width: 8vw;
        }

        /* arrow end */

        /* video */


        .video-1 {
            width: 30vw;
        }

        .video-box {
            width: 100% !important;
        }

        /* video end */

        /* content start */
        .content-text p {
            color: rgb(25, 46, 67);
        }

        h4 {
            font-family: "Myanmar Text" !important;
            padding: 4rem;
        }

        .content-1 p,
        .content-2 p,
        .content-3 p,
        .content-4 p,
        .content-5 p,
        .content-6 p,
        .content-7 p {
            /* font-size: 1.1vw; */
            color: rgb(25, 46, 67);
            text-align: justify;
            /* font-family: "Myanmar Text" !important; */
        }

        /* content-1-2 */

        .content-1-2 {
            display: flex;
            /* width: 80vw; */
            /* margin: 10vw 10vw 2vw 10vw; */
        }

        .content-1,
        .content-2 {
            width: 50%;
            height: 100%;
            display: flex;
            flex-direction: column;
            justify-content: center;
            align-items: center;
            flex-grow: 1;
        }

        .content-1 {
            padding: 0 2.5vw 0 0;
        }

        .content-2 {
            padding: 0 0 0 2.5vw;
        }

        /* content-3 */

        .content-3 {
            display: flex;
            flex-direction: column;
            align-items: center;
            justify-content: center;
            /* width: 60vw; */
            /* height: 43vw; */
            /* margin: 0vw 20vw; */
        }

        /* content-4 */

        .content-4 {
            display: flex;
            flex-direction: column;
            align-items: center;
            /* width: 60vw; */
            /* height: 50vw; */
            /* margin: 2vw 20vw; */
        }

        .content-5 {
            display: flex;
            flex-direction: column;
            align-items: center;
            /* width: 60vw; */
            /* height: 68vw; */
            /* margin: 2vw 20vw; */
        }

        .content-5-h4 {
            align-self: flex-start;
            color: rgb(25, 46, 67);
            text-align: justify;
            /* font-size: 1.5vw; */
        }

        .content-mask {


            flex-direction: column;
            position: absolute;
        }

        .content-mask-0 {

            width: 100%;
            height: 50%;
            background-color: rgb(25, 46, 67);

            left: 0;
            float: left;
        }

        .content-mask-1 {
            width: 100%;
            height: 50%;
            background-color: rgb(255, 55, 68);
            top: 11vw;
            position: absolute;
            right: 0;
            float: right;
        }

        .content-mask-2 {

            width: 100%;
            height: 50%;
            background-color: rgb(25, 46, 67);

            left: 0;
            float: left;
        }

        .content-mask-3 {
            width: 100%;
            height: 50%;
            background-color: rgb(255, 55, 68);
            top: 9vw;
            position: absolute;
            right: 0;
            float: right;
        }

        .content-6 {
            /* width: 80vw; */
            /* margin: 2vw 10vw; */
            height: 35vw;

        }

        .content-mask-6 {
            width: 100%;
            height: 22vw;
        }

        .content-6 p {
            /* font-size: 1.1vw; */
            text-align: justify;

        }

        .content-7 {
            /* width: 80vw; */
            height: 54vw;
            /* margin: 2vw 10vw; */
        }

        .content-mask-7 {
            width: 100%;
            height: 18vw;
        }

        .content-7 p {
            /* font-size: 1.1vw; */
            text-align: justify;

        }

        /* content end */

        /* table */

        /* table,
        table tr th,
        table tr td {
            border: 2px solid #000000;
            color: rgb(25, 46, 67);
            font-family: "Myanmar Text" !important;
            font-size: 1vw;
        }

        td {
            padding: 0.5em;
        }

        .tr-double {
            background-color: rgb(217, 217, 217);
        }

        table {
            width: 65vw;
            height: 40vw;
            min-height: 25px;

            text-align: center;
            border-collapse: collapse;
        }

        .my-vertical-align {
            display: flex;
            align-items: center;
            flex-wrap: wrap;
        } */

        /* table end */

        /* content-design end */
        .content-safety-4 {
            text-indent: 1em;
            text-align: justify;
            display: flex;
            justify-content: center;
            align-items: center;
            flex-direction: column;
        }
    </style>
    <!-- standard head -->
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="viewport" content="width=device-width, initial-scale=1">
    <script type="text/javascript"
        src="https://2019.igem.org/wiki/index.php?title=Team:SYSU-Medicine/js/jquery&action=raw&ctype=text/javascript"></script>
    <link type="text/css" rel="stylesheet"
        href="https://2019.igem.org/wiki/index.php?title=Team:SYSU-Medicine/css/default&action=raw&ctype=text/css" />
    <script type="text/javascript"
        src="https://2019.igem.org/wiki/index.php?title=Team:SYSU-Medicine/js/home&action=raw&ctype=text/javascript"></script>
    <link rel="stylesheet"
        href="https://2019.igem.org/wiki/index.php?title=Team:SYSU-Medicine/css/bootstrap&action=raw&ctype=text/css">
    <script
        src="https://2019.igem.org/wiki/index.php?title=Team:SYSU-Medicine/js/bootstrap&action=raw&ctype=text/javascript"></script>
    <link type="text/css" rel="stylesheet"
        href="https://2019.igem.org/wiki/index.php?title=Team:SYSU-Medicine/css/style&action=raw&ctype=text/css" />
    <!-- standard head end -->
    <!-- <link type="text/css" rel="stylesheet"
        href="https://2019.igem.org/wiki/index.php?title=Team:SYSU-Medicine/css/safety&action=raw&ctype=text/css" />
    <script type="text/javascript"
        src="https://2019.igem.org/wiki/index.php?title=Team:SYSU-Medicine/js/safety&action=raw&ctype=text/javascript"></script> -->

    <!-- <link type="text/css" rel="stylesheet" href="safety.css"> -->
    <!-- <script src="safety.js"></script> -->
    <!-- <link type="text/css" rel="stylesheet" href="./navigation.css">
    <script src="./navigation.js"></script> -->


    <title>INSPIRATION</title>

</head>

<body>
    <!-- <div class="debug" style= "position:fixed;top:6rem">
        <a class="a">a</a>
    </div> -->
    <div class="container">
        <div class="row">
            <div class="col-sm-12 column">
                <nav class="navigation" id="nav-top">
                    <ul class="navigation-list nav-justified">
                        <div class="navigation-blue navigation-div">
                            <li class="navigation-item activate ">
                                <a class="navigation-item-link "
                                    href="https://2019.igem.org/Team:SYSU-Medicine">Home</a>
                                <ul class="navigation-dropdown-panel"></ul>
                            </li>
                            <li class="navigation-item dropdown">
                                <a class="navigation-item-link ">Project</a>
                                <ul class="navigation-dropdown-panel ">
                                    <li class="navigation-subitem">
                                        <a href="https://2019.igem.org/Team:SYSU-Medicine/Description">Description</a>
                                    </li>
                                    <li class="navigation-subitem">
                                        <a href="https://2019.igem.org/Team:SYSU-Medicine/Design">Design</a>
                                    </li>
                                    <li class="navigation-subitem">
                                        <a href="https://2019.igem.org/Team:SYSU-Medicine/Results">Results</a>
                                    </li>
                                    <li class="navigation-subitem">
                                        <a href="https://2019.igem.org/Team:SYSU-Medicine/Experiments">Experiments</a>
                                    </li>
                                    <li class="navigation-subitem">
                                        <a href="https://2019.igem.org/Team:SYSU-Medicine/Inspiration">Inspiration</a>
                                    </li>
                                </ul>
                            </li>
                            <li class="navigation-item dropdown">
                                <a class="navigation-item-link">Model</a>
                                <ul class="navigation-dropdown-panel">
                                    <li class="navigation-subitem">
                                        <a href="https://2019.igem.org/Team:SYSU-Medicine/Model">Overview</a>
                                    </li>
                                    <li class="navigation-subitem">
                                        <a href="https://2019.igem.org/Team:SYSU-Medicine/M1_Cultivation">M1 Cultivation
                                        </a>
                                    </li>
                                    <li class="navigation-subitem">
                                        <a href="https://2019.igem.org/Team:SYSU-Medicine/Injection_System">Injection
                                            System
                                        </a>
                                    </li>
                                    <li class="navigation-subitem">
                                        <a href="https://2019.igem.org/Team:SYSU-Medicine/TES">T. E. S.</a>
                                    </li>
                                    <li class="navigation-subitem">
                                        <a href="https://2019.igem.org/Team:SYSU-Medicine/Future">Future</a>
                                    </li>
                                </ul>
                            </li>
                            <li class="navigation-item dropdown ">
                                <a class="navigation-item-link">Human Practices</a>
                                <ul class="navigation-dropdown-panel ">
                                    <li class="navigation-subitem">
                                        <a href="https://2019.igem.org/Team:SYSU-Medicine/Human_Practices">Overview
                                        </a>
                                    </li>
                                    <li class="navigation-subitem">
                                        <a href="https://2019.igem.org/Team:SYSU-Medicine/Integrated_Practices">Integrated
                                            Practices
                                        </a>
                                    </li>
                                    <li class="navigation-subitem">
                                        <a href="https://2019.igem.org/Team:SYSU-Medicine/Public_Engagement">Education &
                                            Engagement
                                        </a>
                                    </li>
                                </ul>
                            </li>

                        </div>
                        <div class="navigation-red navigation-div">
                            <li class="navigation-item dropdown ">
                                <a class="navigation-item-link ">Parts</a>
                                <ul class="navigation-dropdown-panel ">
                                    <li class="navigation-subitem">
                                        <a href="https://2019.igem.org/Team:SYSU-Medicine/Parts">Parts Overview</a>
                                    </li>
                                    <li class="navigation-subitem">
                                        <a href="https://2019.igem.org/Team:SYSU-Medicine/Parts#Basic_Part">Basic
                                            Parts</a>
                                    </li>
                                    <li class="navigation-subitem">
                                        <a href="https://2019.igem.org/Team:SYSU-Medicine/Parts#Composite_Part">Composite
                                            Parts
                                        </a>
                                    </li>
                                    <li class="navigation-subitem">
                                        <a href="https://2019.igem.org/Team:SYSU-Medicine/Parts#Part_Collection">Part
                                            Collection
                                        </a>
                                    </li>
                                </ul>
                            </li>

                            <li class="navigation-item ">
                                <a class="navigation-item-link"
                                    href="https://2019.igem.org/Team:SYSU-Medicine/Safety">Safety</a>
                                <ul class="navigation-dropdown-panel"></ul>
                            </li>
                            <li class="navigation-item ">
                                <a class="navigation-item-link"
                                    href="https://2019.igem.org/Team:SYSU-Medicine/Medal">Awards</a>
                                <ul class="navigation-dropdown-panel">
                                    <li class="navigation-subitem">
                                        <a href="https://igem.org/2019_Judging_Form?team=SYSU-Medicine">Judging</a>
                                    </li>
                                </ul>
                            </li>
                            <li class="navigation-item dropdown ">
                                <a class="navigation-item-link ">Team</a>
                                <ul class="navigation-dropdown-panel ">
                                    <li class="navigation-subitem">
                                        <a href="https://2019.igem.org/Team:SYSU-Medicine/Team">Team Members</a>
                                    </li>
                                    <li class="navigation-subitem">
                                        <a
                                            href="https://2019.igem.org/Team:SYSU-Medicine/Collaborations">Collaborations</a>
                                    </li>
                                    <li class="navigation-subitem">
                                        <a href="https://2019.igem.org/Team:SYSU-Medicine/Attributions">Attributions</a>
                                    </li>
                                </ul>
                            </li>
                        </div>

                    </ul>
                </nav>
            </div>
        </div>
    </div>

    <!-- <div class="piano-subpage piano-subpage-demo">
    <div id="content-design-0-key" class="piano-subpage-key piano-subpage-key-0"><div class="key-kernel key-kernel-0"></div></div>
    <div id="content-design-1-key" class="piano-subpage-key piano-subpage-key-1"><div class="key-kernel key-kernel-1"></div></div>
    <div id="content-design-2-key" class="piano-subpage-key piano-subpage-key-2"><div class="key-kernel key-kernel-2"></div></div>
    <div id="content-design-3-key" class="piano-subpage-key piano-subpage-key-3"><div class="key-kernel key-kernel-3"></div></div>
    <div id="content-design-4-key" class="piano-subpage-key piano-subpage-key-4"><div class="key-kernel key-kernel-4"></div></div>
    <div id="content-design-5-key" class="piano-subpage-key piano-subpage-key-5"><div class="key-kernel key-kernel-5"></div></div>
    </div> -->
    <!-- <div class="title-margin">
        <div class="row clearfix">
            <div class="col-xs-10">
                <div class="title-box">
                    <h1 class="title">
                        <span class="title-has-mask playing">Human Practices</span>
                        <span class="title-mask playing"></span>
                    </h1>
                </div>
            </div>
        </div>
    </div> -->
    <div class="clearfix" style="margin-bottom: 18em;"></div>
    <div class="container-fluid std-content">
        <div class="row">
            <div class="col-xs-6 col-xs-offset-3">
                <div class="title-box-new title-big">
                    <div class="title-box-mask"></div>
                    <div class="title-box-title">
                        <h1>INSPIRATION</h1>
                    </div>
                </div>
            </div>
        </div>
        <!-- <div class="clearfix" style="margin-bottom: 5em;"></div>
        <div class="row">
            <div class="col-xs-10 col-xs-offset-1">
                <div class="title-box-new title-0">
                    <div class="title-box-mask"></div>
                    <div class="title-box-title">
                        <h1>Inspiration</h1>
                    </div>
                </div>
            </div>
        </div> -->
        <div class="clearfix" style="margin-bottom: 5em;"></div>

        <div class="row">
            <div class="col-xs-8 col-xs-offset-2">
                <div class="content-safety content-safety-4">
                    <p>Nowadays, there are tons of data on the importance and dangers of cancer. We have witnessed the
                        suffering of our patients, the incessant coughing of patients with lung cancer, the excruciating
                        appearance of patients with stomach cancer, and the huge abdomen filled with ascites of patients
                        with liver cancer. All this inspired us to look for a treatment that combines the strengths of
                        the
                        current approaches.</p>
                    <p> Previous studies have shown that targeted and immune-based therapies have already transformed
                        the
                        standard-of care for several malignancies. Oncolytic virus, as an attractive therapeutic
                        combination
                        of the advantage of tumor-specific cell lysis together with immune stimulation, are emerging as
                        important agents in cancer treatment.</p>
                    <p> M1 is a strain of Getah-like alphavirus that was isolated from culicine mosquitoes collected on
                        Hainan Island of China which possesses selective and potent antitumor activity through
                        intravenous
                        administration [1]. Compared with other oncolytic virus, the most significant advantage of M1 is
                        that it is highly safe and can be injected intravenously. In addition, M1 virus has high
                        targeting
                        ability and broad anticancer spectrum, however, it does not have a significant oncolytic effect
                        on
                        all subtypes of tumor cells. Thus we further study the mechanism of M1, it is generally believed
                        that the limited application of M1 virus is mainly attributed to pathways involved by ZAP, RHOQ,
                        IRE1α and MXRA8 in insensitive tumor cells, lead to the impairment of invasion and replication
                        of
                        the virus [2]. However, since the underlying genesis and development mechanism of tumor itself
                        is
                        still far from being thoroughly studied, it is more reasonable to find a solution so that the
                        anti-cancer spectrum of M1 can no longer be restricted by the limitations of the pathways in
                        tumor
                        cells.</p>
                    <img style="120%" src="https://2019.igem.org/wiki/images/b/bd/T--SYSU-Medicine--ins_1.png">
                    <p style="font-size: 14px;">Figure1：The key molecular mechanisms of oncolytic virus M1 targeting
                        tumor cells include zinc finger antiviral protein ZAP, RHO family protein TC10, and UPR
                        signaling molecule IRE1α.</p>
                    <p>One of the most remarkable features of tumors is their limitless replicative potential which was
                        acquired during tumor progression and was essential for the development of their malignant
                        growth
                        state [3]. The ability of unlimited proliferation is reflected in the hyperactive transcription
                        process at the cellular level. Therefore, we want to find a means to interfere with tumor cells
                        at
                        the transcriptional level and then enhance the infection rate and lethality of M1.</p>
                    <p>Surprisingly, many chemotherapy drugs work through this mechanism. Actinomycin D, as a typical
                        representative among actinomycins, has been widely used in clinical practice since 1954 as an
                        anticancer drug for treating many tumors. The two main mechanisms of its anti-tumor ability are
                        intercalation to DNA and the stabilization of cleavable complexes of topoisomerases I and II
                        with
                        DNA, which interferes with cell transcription, but does not affect alphavirus replication or
                        cytopathic vacuoles formation [4].
                    </p>
                    <img style="width: 80%;" src="https://2019.igem.org/wiki/images/7/7a/T--SYSU-Medicine--ins_2.jpg">
                    <p style="font-size: 14px;">Figure 2: Targeting sites and binding modes of selected type IIA
                        topoisomerase inhibitors and regulatory proteins. Delgado, J.L., et al., Topoisomerases as
                        anticancer targets. Biochem J, 2018. 475(2): p. 373-398.</p>
                    <P>As early as 1963, a study suggested that actinomycin D could enhance the growth of Chikungunya
                        virus, which is also an alphavirus, within tumor cells through some cellular mechanism [5].
                        Also,
                        the yield of SFV could be increased at least 50% in the cells pretreated with actinomycin D [4].
                        More studies have also confirmed that actinomycin D promotes the replication of alphavirus in
                        tumor
                        cells significantly, for it can help to suppress cellular functions which inhibit production of
                        infectious virus particles. Those possible mechanism may include interferon and cyclopentenone
                        prostaglandin A1 (PGA1) [5-7].</P>

                    <P> These chemotherapies, which act on the transcription process, could effectively increase the
                        infection rate of M1 against a variety of tumor cells, however, the broad-spectrum effect also
                        causes serious side effects. All this suggests that there might be a feasible way to expand the
                        anti-cancer profile of M1 while reducing the side effects of chemotherapy drugs by combining the
                        therapies together, fostering their strengths and circumventing the weaknesses.</P>
                    <P>Therefore, we further designed the system to combine M1 virus with chemotherapy drugs for cancer
                        treatment. We engineered M1 with enzyme, and after enzyme was delivered to the cancer cell by M1
                        and expressed, the enzyme can activate subsequently administered prodrugs of chemicals (such as
                        actinomycin D, CB1954) to potent drugs.</P>







                </div>
            </div>

        </div>
    </div>
    <div class="container-fluid std-content">
        <div class="clearfix" style="margin-bottom: 5em;"></div>
        <div class="row">
            <div class="col-xs-10 col-xs-offset-1">
                <div class="title-box-new title-4">
                    <div class="title-box-mask"></div>
                    <div class="title-box-title">
                        <h1>Initial Ideas</h1>
                    </div>
                </div>
            </div>

        </div>
        <div class="clearfix" style="margin-bottom: 5em;"></div>
        <div class="row">
            <div class="col-xs-8 col-xs-offset-2">
                <div class="content-5">




                    <h4 class="content-5-h4">
                        Prior to our initial survey, we had many different ideas for potential projects:
                    </h4>

                    <table class="table table-bordered table-striped">
                        <tr>
                            <td></td>
                            <td><b>Purpose</b></td>
                            <td><b>Benefits</b></td>
                            <td><b>Limitations</b></td>
                        </tr>
                        <tr>
                            <td><b>Directed evolution</b></td>
                            <td>We constructed the M1 with low fidelity RNA polymerase to increase the probability of
                                mutation caused by adaptation, to expand the anti-cancer spectrum of M1 virus by
                                continuous
                                passage.</td>
                            <td>Overcome the limitations of the complex regulation mechanism of virus-host interaction.
                            </td>
                            <td>Mutations are unpredictable;
                                Uncertainty.
                            </td>
                        </tr>
                        <tr>
                            <td><b>Engineer M1 with ligands</b></td>
                            <td>We inserted ligands of receptors that are highly expressed in some tumors, such as EGF,
                                HER2, etc., which aims to enhance the affinity between M1 and insensitive tumor cells.
                            </td>
                            <td>Enhance the affinity between M1 and insensitive tumor cells. </td>
                            <td>The insertion of ligands into the M1 genome may affect the replication of M1.
                            </td>
                        </tr>
                        <tr>
                            <td><b>M1-directed enzyme system</b></td>
                            <td>We used M1 as a viral vector to deliver the gene of enzyme, after the enzyme is
                                expressed,
                                the ability to specifically activate subsequently administered and otherwise inert
                                prodrugs
                                to potent drugs, which allows for a specific therapy with limited systemic side effects.
                            </td>
                            <td>Increase the lethality to tumor cells. It can significantly increase the targeting of
                                chemotherapy drugs and reduce its side effects.
                            </td>
                            <td>The prodrug and M1 virus need to be administered separately.</td>
                        </tr>
                        <tr>
                            <td><b>3D culture</b></td>
                            <td>Better simulation of the vivo environment, to improve the affinity of M1 to insensitive
                                cells
                                and enhance its anti- tumor effect.</td>
                            <td>Reduce the affinity of normal cells and improve the safety of M1; Enhance the oncolysis
                                of
                                M1.</td>
                            <td>The lack of a standard approach.</td>
                        </tr>
                        <tr>
                            <td><b>M1 armed with Cytokines</b></td>
                            <td>Encode cytokine such as IL-2、 IL-4 in the M1 vector to induce T cell responses of
                                sufficient
                                magnitude</td>
                            <td>Enhance adaptive immune responses.</td>
                            <td>Causes premature elimination of M1; It is limited by the rate of infection.</td>
                        </tr>
                        <tr>
                            <td><b>Combination with PD-1 or PD-L1 antibody</b></td>
                            <td>Using OVs to heat up ‘cold’ tumors for immune checkpoint blockade, such as PD L1 or PD1,
                                and
                                then increase the antitumor effect.</td>
                            <td>In a number of other preclinical studies, ICIs have been shown to increase the efficacy
                                of
                                OV therapy involving a variety of viral platforms.</td>
                            <td>Hard to regulate the concentration of drug administration;
                                This brings substantially increased toxicity to patients.
                            </td>
                        </tr>

                    </table>
                    <!-- <h4 class="content-5-h4">However, after we did the pre-experiments of two projects, the results was not
                    as
                    expect. So we decided to try another project to expand the anti-cancer spectrum of M1 virus. We
                    designed to
                    engineer M1 to specifically encode and express enzymes that can convert prodrugs into active
                    therapeutic
                    metabolites and enhance bystander effects of chemicals. Finally, we proved that this project was
                    feasible.
                    </h2> -->

                </div>
            </div>

        </div>
        <div class="clearfix" style="margin-bottom: 5em;"></div>
        <div class="row">
            <div class="col-xs-10 col-xs-offset-1">
                <div class="title-box-new title-4">
                    <div class="title-box-mask"></div>
                    <div class="title-box-title">
                        <h1>Final Project Decision</h1>
                    </div>
                </div>
            </div>

        </div>
        <div class="clearfix" style="margin-bottom: 5em;"></div>
        <div class="row">
            <div class="col-xs-8 col-xs-offset-2">
                <div class="content-5">
                    <p>Though interviewed the professor Yan, and taking into account the innovation and
                        feasibility of each project, we subsequently decide to try the following three projects: 1)
                        Directed
                        evolution; 2) Engineer M1 with ligands; 3) M1-directed enzyme system. However, after we did the
                        pre-experiments of the first two projects, the results can not satisfy our expectation. Thus we
                        decided
                        to the third project to expand the anti-cancer spectrum of M1 virus. We designed to engineer M1
                        to
                        specifically encode and express enzymes that can convert prodrugs into active therapeutic
                        metabolites
                        and enhance bystander effects of chemicals. As the result have shown, we proved that this
                        project
                        was
                        feasible.

                    </p>
                </div>

            </div>
        </div>
    </div>

    <!-- <div class="clearfix" style="margin-bottom: 5em;"></div>
    <div class="row">
        <div class="col-xs-10 col-xs-offset-1">
            <div class="title-box-new title-4">
                <div class="title-box-mask"></div>
                <div class="title-box-title">
                    <h1>Directed evolution</h1>
                </div>
            </div>
        </div>

    </div>
    <div class="clearfix" style="margin-bottom: 5em;"></div>
    <div class="row">
        <div class="col-xs-8 col-xs-offset-2">
            <div class="content-6">
                <div class="content-6-0">
                    <div class="content-text">
                        <p>
                            Since the interaction between virus and host is extremely complex and diverse, and a large
                            number of
                            molecular interaction regulatory networks have not been clarified, the ability to use these
                            molecular
                            mechanisms for virus modification is limited.
                            The biggest difference between oncolytic virus and replicator-deficient virus vectors and
                            other
                            anticancer drugs is that OVs can replicate and mutate, and thus has the potential to evolve
                            under
                            the
                            pressure of natural selection, and the direction of evolution can be directed in a
                            controlled
                            laboratory
                            environment.</p>
                        <p>
                            Therefore, we considered to construct the M1 with low fidelity RNA polymerase to increase
                            the
                            probability of mutation caused by adaptation. In addition, we inserted ligands of receptors
                            that are
                            highly expressed in some tumors, which aims to enhance the affinity between M1 and
                            insensitive tumor
                            cells.</p>
                    </div>
                </div>
                <div class="content-6-1">
                    <div class="content-mask content-mask-6">
                        <div class="content-mask-0"></div>
                        <div class="content-mask-1"></div>
                    </div>
                    <div class="content-text">

                        <p><b>
                                Pros:</b></p>
                        <p>
                            1. Increase the fitness and oncoselectivity of previously engineered oncolytic virus</p>
                        <p>
                            2. Overcome some of the limitations imposed by the complexity of virus–host interactions.
                        </p>
                        <p>
                            3. Combine all the mutation site, it could obtain the high efficiency of new broad-spectrum
                            oncolytic
                            virus M1.</p>
                        <p><b>Cons:</b>
                        </p>
                        <p>
                            1. The mutation is uncertain. It is hard to predict whether M1 will evolve into a new virus
                            which
                            has a
                            boarder anti-tumor spectrum and stronger anti-tumor effect.

                        </p>
                    </div>
                </div>

            </div>
        </div>

    </div>
    <div class="clearfix" style="margin-bottom: 5em;"></div>
    <div class="row">
        <div class="col-xs-10 col-xs-offset-1">
            <div class="title-box-new title-4">
                <div class="title-box-mask"></div>
                <div class="title-box-title">
                    <h1>3D culture</h1>
                </div>
            </div>
        </div>

    </div>
    <div class="clearfix" style="margin-bottom: 5em;"></div>
    <div class="row">
        <div class="col-xs-8 col-xs-offset-2">
            <div class="content-7">
                <div class="content-7-0">
                    <div class="content-text">
                        <p>
                            Three-dimensional cell culture model can better simulate the natural developing environment
                            in vivo.
                            3D
                            cell culture can establish physiological cell-cell and cell-extracellular matrix interaction
                            and
                            restore
                            the metabolic pattern of cells in tissues, so as to be closer to the characteristics of
                            natural
                            tissues.
                            Its physiological correlation is significantly stronger than traditional two-dimensional
                            cell
                            culture.
                            This is important in cancer research.
                            Recent studies have reported that a variety of oncolytic viruses have developed a new
                            generation of
                            oncolytic viruses using three-dimensional culture models, such as adenovirus for the
                            treatment of
                            colon
                            cancer, reovirus for the treatment of glioblastoma, herpes simplex virus for the treatment
                            of
                            melanoma
                            and breast cancer, etc. </p>
                        <p>
                            We considered to use 3D culture to improve the fitness of M1 to insensitive cells, in order
                            to
                            expand
                            the anti-tumor spectrum of M1 and enhance its anti- tumor effect. </p>
                    </div>
                </div>
                <div class="content-7-1">
                    <div class="content-mask content-mask-7">
                        <div class="content-mask-2"></div>
                        <div class="content-mask-3"></div>
                    </div>
                    <div class="content-text">

                        <p><b>Pros:</b>
                        </p>
                        <p>
                            1. It could not only reduce the fitness of normal cells and improve the safety of M1, but
                            also
                            enhance
                            the oncolysis of M1 and develop the next generation of effective oncolytic virus M1.</p>
                        <p>
                            2. The data that we obtained from 3D culture are more clinically relevant. </p>
                        <p><b>Cons:</b>
                        </p>
                        <p>
                            One major problem in the field is the lack of a standard approach in 3D cultures, whereas 2D
                            cell
                            culture practice is standard and roughly comparable. </p>
                        <p>

                    </div>
                </div>

            </div>
        </div>

    </div>
    </div>
    <div class="clearfix" style="margin-bottom: 5em;"></div>
    <div class="row">
        <div class="col-xs-10 col-xs-offset-1">
            <div class="title-box-new title-5">
                <div class="title-box-mask"></div>
                <div class="title-box-title">
                    <h1 class="reference-title">REFERENCE</h1>
                </div>
            </div>
        </div>
    </div>
    <div class="clearfix" style="margin-bottom: 5em;"></div>
    <div class="row">
        <div class="col-xs-8 col-xs-offset-2">
            <div class="reference-content-design">
                <p>[1] Yuan Lin al. Identification and characterization of alphavirus M1 as a selective oncolytic
                    virus
                    targeting ZAP-defective human cancers. PNAS 2014:E4504-E4512
                </p>
            </div>
        </div>
    </div>
    </div> -->
    <div class="clearfix" style="margin-bottom: 10em;"></div>
    <div class="row">
        <div class="col-xs-10 col-xs-offset-1">
            <div class="title-box-new title-5">
                <div class="title-box-mask"></div>
                <div class="title-box-title">
                    <h1 class="reference-title">REFERENCE</h1>
                </div>
            </div>
        </div>
    </div>
    <div class="clearfix" style="margin-bottom: 5em;"></div>
    <div class="row">
        <div class="col-xs-8 col-xs-offset-2">
            <div class="reference-content-safety">
                <p>[1] Hu J, Cai XF, Yan G. Alphavirus M1 induces apoptosis of malignant glioma cells via downregulation
                    and nucleolar translocation of p21WAF1/CIP1 protein. Cell Cycle. 2009;8(20):3328–3339.</p>
                <p>[2] K. Li, C. Hu, F. Xinget al. Deficiency of the IRE1α-Autophagy Axis Enhances the Antitumor Effects
                    of
                    the Oncolytic Virus M1. J Virol，2018;92（6）</p>
                <p> [3] Grimley, P.M., et al., Specific membranous structures associated with the replication of group A
                    arboviruses. J Virol, 1972. 10(3): p. 492-503.</p>
                <p> [4] Douglas Hanahan, Robert A Weinberg, The Hallmarks of Cancer, Cell, Volume 100, Issue 1, 2000,
                    Pages
                    57-70, ISSN 0092-8674.</p>
                <p>[5] GIFFORD, G.E. and E. HELLER, EFFECT OF ACTINOMYCIN D ON INTERFERON PRODUCTION BY 'ACTIVE' AND
                    'INACTIVE' CHIKUNGUNYA VIRUS IN CHICK CELLS. Nature, 1963. 200: p. 50-1.</p>
                <p>
                    [6] Carter, M.F., et al., Effects of actinomycin D and ultraviolet and ionizing radiation on
                    Pichinde
                    virus. J Virol, 1973. 12(1): p. 33-8.</p>
                <p> [7] Burlandy, F.M. and M.A. Rebello, Inhibition of Mayaro virus replication by prostaglandin A(1) in
                    Vero cells. Intervirology, 2001. 44(6): p. 344-9.</p>









            </div>
        </div>
    </div>

    <div class="space" style="height: 30vw;"></div>
</body>
<script type="text/javascript">
    // title
    $(document).ready(function () {
        speed = 250;
        $(".title-box-new").each(function (titlebox_i, title_box) {
            var last = $(title_box).offset().top - $(window).scrollTop();
            var viewheight = window.innerHeight / 5 * 4;
            if (last < viewheight) {
                if ($(title_box).hasClass("played")) { } else {
                    $(title_box).addClass("played");

                    $(title_box).children(".title-box-mask").addClass("title-box-mask-left");
                    $(title_box).children(".title-box-mask").animate({ width: $(title_box).find("h1").outerWidth() }, speed, "swing", function () {
                        $(title_box).children(".title-box-mask").removeClass("title-box-mask-left");
                        // console.log($(title_box).width());
                        // console.log($(title_box).find("h1").width());
                        console.log(parseInt($(title_box).find(".title-box-title").css("border-left-width")));
                        var cache = $(title_box).width() - $(title_box).find("h1").outerWidth();
                        $(title_box).children(".title-box-mask").css("right", cache);
                        // $(title_box).children(".title-box-mask").addClass("title-box-mask-right");
                        $(title_box).children(".title-box-title").animate({ opacity: "100" }, speed / 2);
                    });
                    $(title_box).children(".title-box-mask").animate({ width: "0" }, speed, "swing");
                }


            }
        });
    })
    $(document).scroll(function () {
        speed = 250;
        $(".title-box-new").each(function (titlebox_i, title_box) {
            var last = $(title_box).offset().top - $(window).scrollTop();
            var viewheight = window.innerHeight / 5 * 4;
            if (last < viewheight) {
                if ($(title_box).hasClass("played")) { } else {
                    $(title_box).addClass("played");

                    $(title_box).children(".title-box-mask").addClass("title-box-mask-left");
                    $(title_box).children(".title-box-mask").animate({ width: $(title_box).find("h1").outerWidth() }, speed, "swing", function () {
                        $(title_box).children(".title-box-mask").removeClass("title-box-mask-left");
                        // console.log($(title_box).width());
                        // console.log($(title_box).find("h1").width());
                        console.log(parseInt($(title_box).find(".title-box-title").css("border-left-width")));
                        var cache = $(title_box).width() - $(title_box).find("h1").outerWidth();
                        $(title_box).children(".title-box-mask").css("right", cache);
                        // $(title_box).children(".title-box-mask").addClass("title-box-mask-right");
                        $(title_box).children(".title-box-title").animate({ opacity: "100" }, speed / 2);
                    });
                    $(title_box).children(".title-box-mask").animate({ width: "0" }, speed, "swing");
                }


            }
        });
    })

    // title end
    //content
    //mask
    $(document).scroll(function () {
        speed = 700
        $(".content-mask").each(function (titlebox_i, title_box) {
            var last = $(title_box).offset().top - $(window).scrollTop();
            var viewheight = window.innerHeight / 5 * 4;
            if (last < viewheight) {
                if ($(title_box).hasClass("played")) { } else {
                    $(title_box).addClass("played");
                    $(title_box).children().each(function (mask_i, mask) {
                        $(mask).animate({ width: "0" }, speed);
                    });
                    // $(title_box).children(".title-box-mask").addClass("title-box-mask-left");
                    // $(title_box).children(".title-box-mask").animate({ width: $(title_box).width() }, speed,"swing", function () {
                    //     $(title_box).children(".title-box-mask").removeClass("title-box-mask-left");
                    //     $(title_box).children(".title-box-mask").addClass("title-box-mask-right");
                    //     $(title_box).children(".title-box-title").animate({ opacity: "100" }, speed / 2);
                    // });
                    // $(title_box).children(".title-box-mask").animate({ width: "0" }, speed,"swing");
                }


            }
        });
    });
    //p
    $(document).scroll(function () {
        speed = 700
        $("p").each(function (titlebox_i, title_box) {
            var last = $(title_box).offset().top - $(window).scrollTop();
            var viewheight = window.innerHeight / 5 * 4;
            if (last < viewheight) {
                if ($(title_box).hasClass("played")) { } else {
                    $(title_box).addClass("played");
                    $(title_box).animate({ opacity: "100" }, 5000);

                }

            }
        });
    })
    //arrow
    $(document).scroll(function () {
        speed = 700
        $(".arrow").each(function (titlebox_i, title_box) {
            var last = $(title_box).offset().top - $(window).scrollTop();
            var viewheight = window.innerHeight / 5 * 4;
            if (last < viewheight) {
                if ($(title_box).hasClass("played")) { } else {
                    $(title_box).addClass("played");
                    $(title_box).animate({ opacity: "100" }, 5000);

                }

            }
        });
    })
//content end
</script>
<footer>
    <div style="background-color: rgb(25, 46, 67);" class="container-fluid std-content">
        <div class="row">
            <div class="col-xs-10 col-xs-offset-1">
                <div class="row" style="display: flex;align-items: center;">
                    <div class="col-xs-6">
                        <div style="display: flex;align-items: center;" class="row">
                            <div class="col-xs-8">
                                <img style="width: 100%;"
                                    src="https://2019.igem.org/wiki/images/1/13/T--SYSU-Medicine--footer_logo.png">
                            </div>
                            <div class="col-xs-4">
                                <img style="height:8em;" class="img-circle"
                                    src="https://2019.igem.org/wiki/images/f/fe/T--SYSU-Medicine--five_logo.png">
                            </div>
                        </div>
                    </div>
                    <div class="col-xs-6">
                        <br />
                        <p style="color: #fff;opacity: 100;">Address: No.74 Zhongshan Rd.2, Guangzhou, P.R. China</p>
                        <p style="color: #fff;opacity: 100;">ZipCode: 510080</p>

                        <p style="color: #fff;opacity: 100;">E-mail: sysumedicine2019@163.com</p>
                    </div>
                </div>
            </div>
        </div>

    </div>
</footer>

</html>